Skip to content

Article: NAD+ Depletion Drives Cartilage Damage in Osteoarthritis: Preclinical Findings

NAD+ Depletion Drives Cartilage Damage in Osteoarthritis: Preclinical Findings


Synopsis

Earlier research showed that people with osteoarthritis (OA) have lower levels of NAD+, an important energy-related molecule, in their cartilage. This study found that NAD+ levels are reduced in human and animal OA and that this drop is partly caused by increased activity of PARP14, an enzyme that consumes NAD+. Even though the body tries to make more NAD+, inflammation may limit its production. Raising NAD+ levels—through supplements like NMN or NR or by boosting a key NAD-producing enzyme—helped protect cartilage in aging and injury-based OA models. Overall, the findings suggest that faulty NAD+ metabolism contributes to OA and that restoring NAD+ may help slow the disease, though more research is needed.

Journal

Clinical and Translational Medicine

Read more

Cardiovascular Disease

Nicotinamide Riboside and B Vitamins Restore Heart Energy in Heart Failure: Preclinical Findings

Synopsis Heart failure (HF) affects the heart’s energy supply, but current treatments do not directly fix this problem. In a study using mice with established HF, a diet supplemented with three B ...

Read more
Alzheimer's Disease

NAD+ Reverses Alzheimer’s Deficits: Preclinical Findings

Synopsis Alternative splicing defects are common features of aging and Alzheimer's disease (AD). This study identifies a previously unknown way that boosting NAD+ restores brain function: NAD+ hel...

Read more